MARKET

OBIO

OBIO

Orchestra BioMed Holdings Inc
NASDAQ
2.940
+0.290
+10.94%
Pre Market: 2.940 0 0.00% 08:00 05/14 EDT
OPEN
2.720
PREV CLOSE
2.650
HIGH
3.010
LOW
2.650
VOLUME
800
TURNOVER
0
52 WEEK HIGH
8.87
52 WEEK LOW
2.370
MARKET CAP
112.64M
P/E (TTM)
-1.7740
1D
5D
1M
3M
1Y
5Y
1D
Orchestra BioMed Holdings - Breakthrough Device Designation Gives Speculative Optimism
Seeking Alpha · 7h ago
Orchestra BioMed Holdings Is Maintained at Buy by Chardan Capital
Dow Jones · 13h ago
Orchestra BioMed Holdings Price Target Maintained With a $20.00/Share by Chardan Capital
Dow Jones · 13h ago
Chardan Capital Maintains Buy on Orchestra BioMed Hldgs, Maintains $20 Price Target
Benzinga · 14h ago
Orchestra BioMed GAAP EPS of -$0.49, revenue of $0.9M
Seeking Alpha · 23h ago
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates
NASDAQ · 1d ago
ORCHESTRA BIOMED Q1 EPS USD -0.49 VS. IBES ESTIMATE USD -0.48
Reuters · 1d ago
Press Release: Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
Dow Jones · 1d ago
More
About OBIO
More
Orchestra BioMed Holdings, Inc. is a biomedical innovation company. The Company’s lead product candidates include Atrioventricular Interval Modulation (AVIM) therapy for the treatment of hypertension (HTN), the leading risk factor for death worldwide and the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. The Company develops bioelectronic therapies based on patented Cardiac Neuromodulation Therapy (CNT) technology. The AVIM is a bioelectronic therapy candidate designed to substantially and persistently lower blood pressure. Its Virtue SAB is a proprietary drug/device combination product candidate for the treatment of artery disease that is designed to deliver a proprietary, investigational, extended-release formulation of sirolimus (SirolimusEFR) to the vessel wall during balloon angioplasty without the need for balloon coating or a permanent implant.
Recently
Symbol
Price
%Change

Webull offers Orchestra Biomed Holdings Inc stock information, including NASDAQ: OBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OBIO stock methods without spending real money on the virtual paper trading platform.